Asio Capital, LLC Novartis Ag Transaction History

Asio Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$83.5 - $98.47 $1.85 Million - $2.18 Million	-22,157 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $95,245 - $115,204	1,220 Added 5.83%	22,157 $2.09 Million
Q3 2020 Oct 15, 2020	BUY	$82.14 - $91.0 $180,297 - $199,745	2,195 Added 11.71%	20,937 $1.82 Million
Q2 2020 Jul 31, 2020	SELL	$80.93 - $91.1 $65,957 - $74,246	-815 Reduced 4.17%	18,742 $1.64 Million
Q1 2020 Apr 28, 2020	BUY	$70.67 - $99.01 $409,108 - $573,168	5,789 Added 42.05%	19,557 $1.61 Million

Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $1.16 Million - $1.31 Million	13,768 New	13,768 $1.3 Million

1,350

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Asio Capital, LLC with notifications on news.